NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.

New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal Cancers

New research just-published online by JNCCN—Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic GI cancers, it is possible to administer 5-FU solely through continuous infusion, minus the bolus component, without negatively affecting patient outcomes.

New Survey from NCCN Finds Cancer Drug Shortage Management Remains a Moving Target, Impacting Clinical Trials

NCCN shares new data on continued high prevalence for cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.

Multiple New Awards Recognize NCCN as Exceptional Source for Information for Cancer Patients and Caregivers

NCCN Guidelines for Patients earn Hermes Award for electronic media and Communicator Award for medical print content. NCCN Patient Webinars earn Digital Health Award and Viddy Award for outstanding achievement in video and digital production.

Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network

Daniel M. Geynisman, MD, is being announced the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman, Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has a long history of working with NCCN in a variety of roles.

Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi

International collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update consensus harmonized guidelines on several key subjects in oncology, including how best to treat people with both cancer and HIV.

National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—announces 2024 award recipients that include individuals and groups who have made significant and noteworthy impacts on improving cancer care and supporting NCCN’s mission to help all people with cancer to live better lives.

New Findings in JNCCN Illustrate Pathway for Screening High-Risk Individuals for Pancreatic Cancer in PRECEDE Study

New research in the April 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer.

NCCN 2024 Annual Conference Shares Cancer Care Updates for Practical, Immediate Use in Practice

More than 1,700 oncology professionals attended National Comprehensive Cancer Network meeting in Orlando and online, featuring clinical and administrative updates for improving cancer care worldwide, plenary sessions on Lynch syndrome and drug shortages, plus nearly 200 poster abstracts with new research.

Cleveland Clinic’s Dr. Matt Kalaycio Appointed Chair of Board of Directors for National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the election of Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022.